Memorial Sloan Kettering Cancer Center
Center for Laboratory Medicine
327 E 64th St, Ste 526
New York, NY 10065
T (646) 608-1109
Kazunori Murata, PhD
Katie Thoren, PhD
Faculty and Research Interests
|Memorial Sloan Kettering Cancer Center|
|Kazunori Murata, PhD||protein immunology, special chemistry|
|Lakshmi Ramanathan, PhD||clinical chemistry, automated chemistry|
|Dean Carlow, MD, PhD||mass spectrometry, therapeutic drug monitoring|
|Melissa Pessin, MD, PhD||transfusion medicine, clinical chemistry, hematology|
|Ellinor Peerschke, PhD||hematology, hemoglobinopathies, coagulation|
|Samuel McCash, MD||clinical chemistry, hematology, protein immunology|
|Yi-Wei Tang, MD, PhD||clinical microbiology, serology|
|Esther Babady PhD||clinical microbiology, molecular microbiology|
|Katie Thoren PhD||clinical chemistry, special chemistry, toxicology|
|Amanda Blouin MD PhD||clinical chemistry, hematology, protein immunology|
|Columbia College of Physicians and Surgeons|
|Alexander Kratz, MD, PhD||core laboratory, point of care|
|Michael Pesce PhD||clinical chemistry|
|Alex Rai PhD||special chemistry|
|Tiffany Thomas PhD||biochemical genetics|
|Serge Cremers PhD PharmD||therapeutic drug monitoring, mass spectrometry|
Level(s) of training: Postdoctoral
Number of positions available per year: 1 every 2 years
Duration of program: 2 years
Approximate annual salary or stipend: PGY1
Source of funding: Hospital
Current number of trainees: 1
Number of past graduates: 0
Applicants must have earned a PhD, MD, or DO (or equivalent) from an accredited university. Applicants should have successfully completed 30 semester hours (or equivalent) in undergraduate and/or graduate level chemistry or biochemistry at an accredited institution. Applicants are strongly encouraged to have gained exposure to a clinical laboratory and to have taken courses in human anatomy, physiology, and/or pathophysiology prior to application.
Applicants should submit a personal statement describing their interest in clinical chemistry, qualifications, and future goals, along with a current CV. Applications without a personal statement will not be accepted. All applications should be sent via e-mail to email@example.com. Applicants are requested NOT to send any transcripts or letters of recommendation.
Applications are only accepted in alternating years. Fellowships at MSKCC have a start date of July.
Applications will be accepted from August 1, 2020 until filled for the position staring in July 1, 2021. Early application is encouraged.
The Memorial Sloan Kettering Cancer Center (MSKCC) is a worldwide leader in cancer treatment and diagnosis. The Department of Laboratory Medicine provides diagnostic testing for all patients seen at MSKCC, and includes clinical chemistry, hematology, microbiology, point-of-care, cell therapy, flow cytometry, cellular immunology, and transfusion medicine. MSKCC maintains laboratories in the main campus, as well as multiple regional sites located in New Jersey, Westchester County, Long Island and several outpatient sites in Manhattan that collect specimens and perform a limited number of tests on site. The Clinical Chemistry service performs testing in all areas including routine chemistry, critical care testing, cardiac markers, tumor markers, toxicology screening, protein immunology, immunochemistry, mass spectrometry, and point of care testing.
The goal of the two year MSKCC Clinical Chemistry Fellowship Program is to prepare fellows to function as a laboratory director of a high complexity laboratory in a clinical, academic, or industrial environment. Fellows are expected to take the qualifying examinations administered by the ABCC upon completion of their fellowship.
The curriculum consists of two phases. Phase 1 consists of a 12 month series of rotations through clinical chemistry laboratories in the Department of Laboratory Medicine at MSKCC and Columbia University Medical Center. The duration of the rotations are between 1-4 weeks. Fellows may also be assigned short term development or quality projects during this time. Formal instruction in certain topics will be provided via lectures and didactic sessions. In Phase 2, fellows complete a translational research project. Fellows assume increasing responsibility in the laboratories where emphasis will be on projects as well as answering calls from the medical staff. Fellows will also serve as acting laboratory directors during their second year and assume responsibility for laboratory and patient issues under the supervision of an attending director.